FI64598B - Foerfarande foer framstaellning av terapeutiskt anvaendbara imdazo(1,2-a)purin-9-onderivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara imdazo(1,2-a)purin-9-onderivat Download PDF

Info

Publication number
FI64598B
FI64598B FI780427A FI780427A FI64598B FI 64598 B FI64598 B FI 64598B FI 780427 A FI780427 A FI 780427A FI 780427 A FI780427 A FI 780427A FI 64598 B FI64598 B FI 64598B
Authority
FI
Finland
Prior art keywords
formula
compound
purin
methyl
imidazo
Prior art date
Application number
FI780427A
Other languages
English (en)
Finnish (fi)
Other versions
FI64598C (fi
FI780427A (fi
Inventor
Jr Davis L Temple
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI780427A publication Critical patent/FI780427A/fi
Application granted granted Critical
Publication of FI64598B publication Critical patent/FI64598B/fi
Publication of FI64598C publication Critical patent/FI64598C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Claims (2)

1. Förfarande för framställning av terapeutiskt användbara imidazo/I,2-a/purin-9-onderivat med formeln I och farmaceutiskt godtagbara salter därav
2 H Π R -"X9^N8--1 7 1 i»3 ii 4 I87>R N “ ·\5Αν Kr 6 R4 2 4 där R är väte, lägre alkyl eller trifluormetyl, R Mr lägre alkyl, bensyl, som kan vara substituerad med halogen eller lägre 6 7 alkoxij pyridylmetyl eller fenoxietyl och R och R betecknar väte, metyl eller etyl, kännetecknat därav, att en förening med formeln 0 ON il f5 7* 3]— R7 III l<7 8 1.12 nh^N^nAr6 4 g 7 där R , R och R betecknar samma som ovan, reduceras under formyleningsbetingelsen, varvid erhälles en monoformyldiamino-förening med formeln HCO-NH J 's, IV ί ΐ~μ*7 2 ! *6 R4 4 6 7 där R*, R° och R# betecknar sanana som ovan, och den erhällna föreningen med formeln IV cykliseras pyrolytiskt eller genom upphettning med en syraanhydrid eventuellt i närvaro av trietylortoformiat, och om sä önskas omvandlas den erhällna föreningen med formeln I tili ett farmaceutiskt godtagbart sait.
FI780427A 1977-02-14 1978-02-09 Foerfarande foer framstaellning av terapeutiskt anvaendbara imdazo(1,2-a)-purin-9-onderivat FI64598C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76829177A 1977-02-14 1977-02-14
US76829177 1977-02-14

Publications (3)

Publication Number Publication Date
FI780427A FI780427A (fi) 1978-08-15
FI64598B true FI64598B (fi) 1983-08-31
FI64598C FI64598C (fi) 1983-12-12

Family

ID=25082078

Family Applications (1)

Application Number Title Priority Date Filing Date
FI780427A FI64598C (fi) 1977-02-14 1978-02-09 Foerfarande foer framstaellning av terapeutiskt anvaendbara imdazo(1,2-a)-purin-9-onderivat

Country Status (22)

Country Link
JP (1) JPS53103497A (sv)
AR (1) AR229078A1 (sv)
AT (1) AT363948B (sv)
AU (1) AU519271B2 (sv)
BE (1) BE863525A (sv)
CS (1) CS207499B2 (sv)
DD (1) DD138211A5 (sv)
DE (1) DE2806199A1 (sv)
DK (1) DK60578A (sv)
ES (1) ES466981A1 (sv)
FI (1) FI64598C (sv)
FR (1) FR2380282A1 (sv)
GB (1) GB1596320A (sv)
GR (1) GR72456B (sv)
HU (1) HU182460B (sv)
IE (1) IE46456B1 (sv)
IL (1) IL54037A (sv)
NO (1) NO780504L (sv)
PH (1) PH14777A (sv)
SE (2) SE7801637L (sv)
YU (4) YU40578A (sv)
ZA (1) ZA78870B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU45690B (sh) * 1984-12-22 1992-07-20 Krka Tovarna Zdraviln.Sol.O. Postopek za pripravo 9-(2-hidroksietoksimetil)-gvanina
JP2988711B2 (ja) * 1989-10-20 1999-12-13 協和醗酵工業株式会社 縮合プリン誘導体
ZA914727B (en) * 1990-06-21 1992-03-25 Schering Corp Polycyclic guanine derivatives
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
US7772232B2 (en) 2004-04-15 2010-08-10 Bristol-Myers Squibb Company Quinazolinyl compounds as inhibitors of potassium channel function
WO2007150025A2 (en) 2006-06-23 2007-12-27 Incyte Corporation Purinone derivatives as hm74a agonists

Also Published As

Publication number Publication date
ES466981A1 (es) 1979-08-16
JPS53103497A (en) 1978-09-08
AR229078A1 (es) 1983-06-15
PH14777A (en) 1981-12-09
FR2380282B1 (sv) 1982-03-05
IE780310L (en) 1978-08-14
AU3322178A (en) 1979-08-23
DE2806199A1 (de) 1978-08-17
YU198882A (en) 1983-04-30
ATA106778A (de) 1981-02-15
IL54037A (en) 1982-02-28
AU519271B2 (en) 1981-11-19
FI64598C (fi) 1983-12-12
IL54037A0 (en) 1978-04-30
GR72456B (sv) 1983-11-09
SE7801637L (sv) 1978-08-15
ZA78870B (en) 1979-01-31
SE8301408D0 (sv) 1983-03-15
IE46456B1 (en) 1983-06-15
CS207499B2 (en) 1981-07-31
YU198682A (en) 1983-04-30
NO780504L (no) 1978-08-15
SE8301408L (sv) 1983-03-15
YU198782A (en) 1983-04-30
FR2380282A1 (fr) 1978-09-08
AT363948B (de) 1981-09-10
DK60578A (da) 1978-08-15
HU182460B (en) 1984-01-30
BE863525A (fr) 1978-07-31
FI780427A (fi) 1978-08-15
DD138211A5 (de) 1979-10-17
GB1596320A (en) 1981-08-26
YU40578A (en) 1983-04-30

Similar Documents

Publication Publication Date Title
US8618288B2 (en) Pyrimidine compounds as serotonin receptor modulators
US7598255B2 (en) Pyrimidine compounds as serotonin receptor modulators
DE60002554T2 (de) Pyrazino(aza)indolderivate
US4298734A (en) Diazaheterocyclopurines and triazolopyrimidines
KR101353268B1 (ko) 세로토닌 수용체 모듈레이터로서의 피리미딘 화합물
CA2389553C (en) Heteroaryl-diazabicycloalkanes
US4642345A (en) 6,7-dihydro-3H-imidazo[1,2-a]-purine-9(4H)-ones
AU2007332439A1 (en) Therapeutic agent for urinary tract disease
JP2002518395A (ja) 縮合アゼピノン型サイクリン依存性キナーゼ阻害物質
US4404380A (en) Triazolopyrimidines
CA2799926A1 (en) Heterocyclic compounds as janus kinase inhibitors
FI66868C (fi) Foerfarande foer framstaellning av imidazo(1,2-a)kinoxalinmetanoler anvaendbara saosom laekemedel
SE445642B (sv) Antiallergiskt och antiastmatiskt verksamma azolopyrimidinoner samt forfarande for deras framstellning
US4366156A (en) Antiallergic methods using diazaheterocyclopurines
US4489078A (en) Diazaheterocyclopurines used as anti-broncho spasmatics and vasodilators
JPH0146514B2 (sv)
FI64598B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara imdazo(1,2-a)purin-9-onderivat
FI76336B (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyrido/2,3-d/pyrimidin-5-oner.
JP6633246B2 (ja) ヒトpde1阻害薬として有用なトリアゾロピラジノン誘導体
JP2000506874A (ja) 抗喘息性、抗アレルギー性、抗炎症性および免疫調節作用を有する1,3,5―トリ置換されたインダゾール誘導体
JP5690594B2 (ja) 3−(スルホニル)ピラゾロ[1,5−a]ピリミジン−セロトニン5−HT6受容体のアンタゴニスト、その調製の方法及び使用
CZ20022222A3 (cs) Nové substituované pyrazolo [4,3-e] diazepiny, farmaceutické kompozice obsahující tyto diazepiny, jejich použití jako léčiva a způsoby jejich přípravy
JPS5953493A (ja) 新規なチエノ−チアゾ−ル誘導体
FI59409C (fi) Foerfarande foer framstaellning av antiallergiskt aktiva n-(5-tetrazolyl)-1-okso-1h-6-(r3-substituerade)-pyrimido(1,2-a)kinolin-2-karboxamider
FI85485B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 3-(1h-tetrazol-5-yl)tieno/2,3-d/pyrimidin-4(3h) -onderivat.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BRISTOL-MYERS CO